EUVIMEDEUVIMED entdecken
Crossref

Serum Levels of Activin A: Predictor of Insulin Resistance and Atherosclerosis in Prediabetics

Ajay Chauhan, Asmita Gupta, Parul Goyal, Tarun Kumar

Journal of the Association of Physicians of India · 2023

DOI: 10.5005/japi-11001-0211 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of the Association of Physicians of India, 2023. Verfasst von Ajay Chauhan und 3 weiteren Autor:innen. Beteiligte Einrichtung: Professor;Corresponding Author. Hauptthemen laut MEDLINE: Insulin Resistance, Prediabetic State, Atherosclerosis, Cardiovascular Diseases. Die Arbeit wurde bisher 1-mal zitiert (Crossref).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Pathological effects of dysglycemia and insulin resistance on atherosclerosis and cardiac remodeling starts as early as in the prediabetic state before the onset of overt diabetes. Activin A is a molecule with multiple functions, including an important part in glucose homeostatic mechanisms as well as inflammatory processes and is therefore being researched as a useful novel biomarker for prompt recognition of the risk of cardiovascular disease (CVD) in prediabetic individuals, thereby helping in disease prognostication and early institution of therapeutic measures.

Objective

The study aimed to measure serum levels of activin A in prediabetic patients and evaluate them in comparison to normoglycemic controls. The association of activin A with carotid intima media thickness (CIMT), left ventricular diastolic dysfunction (LVDD), and homeostatic assessment of insulin resistance (HOMA-IR) was also studied. Materials and methods: A total of 60 prediabetic cases and 60 normoglycemic control subjects [matched as per age, gender, and body mass index (BMI)] were recruited. Measurement of serum glucose levels (fasting and postprandial) and fasting insulin levels and glycated hemoglobin (HbA1c) levels were done in all the subjects. The values of HOMA-IR were computed using established formulae. Enzyme-linked immunosorbent assay (ELISA) kits were used for the evaluation of serum levels of activin A in both groups. Parameters for the two groups were compared. In the cases, CIMT (using B-mode ultrasound) and LVDD (using two-dimensional (2D) echocardiography) were measured and correlated with activin A levels.

Results

Serum fasting insulin (mIU/L) was considerably higher in cases than in the controls (p < 0.001). HOMA-IR median [interquartile range (IQR)] was 4 (3.25–4.93) in some cases, and that in the control group was 1.2 (0.88–1.5) (p < 0.001). Serum activin A levels in the cases group had a median (IQR) of 263.55 (227.1–279.5) ng/mL, which was substantially greater as compared to the control group 159.9 (150.7–178.7) ng/mL (p < 0.001). A significant positive association of serum activin A levels with HOMA-IR (ρ = 0.75, p < 0.001) and CIMT (ρ = 0.50, p < 0.001) was found. In LVDD grade I and II groups, the serum levels of activin A were 257.86 (219.3–271.2) ng/mL and 269 (244.19–291.5) ng/mL, respectively (p = 0.12).

Conclusion

A substantial proportion of morbidity and mortality related to dysglycemic states can be attributed to cardiovascular complications. Elevated levels of activin A in prediabetes can act as an indicator of subclinical CVD leading to early diagnosis and intervention

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Insulin ResistancePrediabetic StateAtherosclerosisCardiovascular DiseasesInsulinsHumansCarotid Intima-Media ThicknessGlucoseRisk FactorsBlood GlucoseInsulinActivins

Substanzen

GlucoseInsulinsBlood GlucoseInsulinactivin AActivins

Autor:innen und Institutionen

  • Professor;Corresponding Author.
  • Postgraduate Resident, Department of Medicine.
  • Professor, Department of Biochemistry.
  • Professor, Department of Cardiology, Atal Bihari Vajpayee Institute of Medical Sciences & Dr Ram Manohar Lohia Hospital, Delhi, India.

Zitieren

APA

Chauhan, A., Gupta, A., Goyal, P., & Kumar, T. (2023). Serum Levels of Activin A: Predictor of Insulin Resistance and Atherosclerosis in Prediabetics. Journal of the Association of Physicians of India. https://doi.org/10.5005/japi-11001-0211

Vancouver

Chauhan A, Gupta A, Goyal P, Kumar T. Serum Levels of Activin A: Predictor of Insulin Resistance and Atherosclerosis in Prediabetics. Journal of the Association of Physicians of India. 2023. doi:10.5005/japi-11001-0211

BibTeX
@article{Chauhan2023,
  author = {Chauhan, Ajay and Gupta, Asmita and Goyal, Parul and Kumar, Tarun},
  title = {Serum Levels of Activin A: Predictor of Insulin Resistance and Atherosclerosis in Prediabetics},
  journal = {Journal of the Association of Physicians of India},
  year = {2023},
  doi = {10.5005/japi-11001-0211}
}
Kostenlos starten →